← Research LibraryThe BriefFY2025 20-F · headline figures audited against SEC data
Rentokil grew revenue 4.4% to $6.91B and free cash flow 17.7%, but a $201 million top-up to Terminix termite damage provisions cut operating margin 128 bps as a new CEO takes over
The read at a glance✓ Audited against SEC data
- Growth — Revenue up 4.4% to $6.91B; North America up 3.1%, International up 6.6%Note
- Profitability — Operating income $0.58B; operating margin down 128 bps to 8.45%Watch
- Balance sheet — Net debt $3,650 million, down from $4,017 millionNote
- Accounting quality — Clean PwC audit; internal controls effective; termite provision is a key judgementNote
- Capital allocation — Dividends $0.30B, up 4.1%; no buybacks; 36 bolt-on acquisitionsNote
- Termite claims — $201 million of added provisions for legacy Terminix claimsWatch
Business
Rentokil Initial is a UK-based pest control and hygiene services company working in 90 countries under the Rentokil, Terminix, Initial and Ambius brands. Pest Control was 83% of 2025 revenue and Hygiene & Wellbeing 17%; North America, built largely on the 2022 Terminix acquisition, was 62% and the US alone 61%. Most revenue is recurring service contracts, with job and product sales on top.
Latest filings
- 6-K · Company announcement (foreign filer)2026-10-06
- 6-K · Company announcement (foreign filer)2026-09-30
- 6-K · Company announcement (foreign filer)2026-09-22
- 6-K · Company announcement (foreign filer)2026-08-27
- 6-K · Company announcement (foreign filer)2026-08-13
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about RENTOKIL INITIAL PLC /FI, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.